Dr. Michael R. Bubb, MD

Dr. Bubb practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Bubb's NPI, 1770599094, was assigned on July 31, 2006. Dr. Bubb graduated from The Johns Hopkins University School of Medicine in 1985. Dr. Bubb holds Florida license ME67086.

Dr. Bubb's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Bubb's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bubb practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Bubb's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Bubb is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Bubb's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists arteritis, arthritis, joint arthropathy, lupus, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Bubb treats.

CMS data shows 84 Medicare services from Dr. Bubb across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $6,247 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Dr. Bubb in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have arthritis, and 74% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bubb's median patient age at 70, with 72% women.

In 2024, Dr. Bubb wrote 387 Medicare Part D claims for 44 patients. 64% of them were for generic drugs. CMS names the drug for 298 of them, across 8 drugs with 11 or more claims each, at $658,194 in total drug cost. In 2023, CMS named 419 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Bubb for performance year 2024, reported through an alternative payment model (APM). Dr. Bubb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 54 papers to Dr. Bubb, published from 2001 to 2024. 2006 was the busiest year, with 3. The most frequent topics are Actins, Microfilament Proteins and Amino Acid Sequence. Dr. Bubb has published most often in J Biol Chem. Dr. Bubb's most frequent co-authors are Edward R. Block, MD, Edward Kaiwah Chan, MD and Sophia Mae Edwards-Bennett, MD, PhD.

Dmand AI links Dr. Bubb to 1 clinical trial. Conditions studied include Giant Cell Arteritis and Vasculitis, Central Nervous System. Open Payments lists research payments to Dr. Bubb that name 1 trial.

CMS Open Payments shows 97 general payments to Dr. Bubb from 15 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 43% of the total. UCB, Inc. paid the most, $5,009. It also lists 29 research payments totaling $3,674 from 2018 to 2024, naming 1 clinical trial.

Dr. Bubb graduated from The Johns Hopkins University School of Medicine in 1985.

Dr. Bubb is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.